Cargando…

Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort

CONTEXT: Previous studies of menopausal age and length of reproductive life on bone are limited by retrospective reproductive histories, being cross-sectional, or lacking gold standard bone technologies or information on hormone replacement therapy (HRT) or surgical treatment. OBJECTIVE: The objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuh, D., Muthuri, S., Cooper, R., Moore, A., Mackinnon, K., Cooper, C., Adams, J. E., Hardy, R., Ward, K. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052353/
https://www.ncbi.nlm.nih.gov/pubmed/27472291
http://dx.doi.org/10.1210/jc.2016-1828
_version_ 1782458217303900160
author Kuh, D.
Muthuri, S.
Cooper, R.
Moore, A.
Mackinnon, K.
Cooper, C.
Adams, J. E.
Hardy, R.
Ward, K. A.
author_facet Kuh, D.
Muthuri, S.
Cooper, R.
Moore, A.
Mackinnon, K.
Cooper, C.
Adams, J. E.
Hardy, R.
Ward, K. A.
author_sort Kuh, D.
collection PubMed
description CONTEXT: Previous studies of menopausal age and length of reproductive life on bone are limited by retrospective reproductive histories, being cross-sectional, or lacking gold standard bone technologies or information on hormone replacement therapy (HRT) or surgical treatment. OBJECTIVE: The objective of the study was to investigate age at menopause, length of reproductive life, and HRT use in relation to volumetric and areal bone mineral density (vBMD, aBMD), bone size, and strength in women aged 60–64 years. DESIGN: This was a birth cohort study that followed up for 64 years with prospective measures of age at menarche and menopause and monthly HRT histories. SETTING: The study was conducted in England, Scotland, and Wales. PARTICIPANTS: Participants included 848 women with a known type of menopause and bone measures at 60–64 years. MAIN OUTCOME MEASURES: Peripheral quantitative computed tomography measurements of the distal radius total and trabecular vBMD were measured. Diaphyseal radius total and medullary cross-sectional area, cortical vBMD, and polar strength strain index (SSI); dual-energy x-ray absorptiometry measurements of aBMD at the lumbar spine and total hip were also measured. RESULTS: A 10-year increase in age at natural (but not surgical) menopause was associated with 8.2% (95% confidence interval [CI] 1.3%–15.1%, P = .02) greater trabecular vBMD and a 6.0% (95% CI 0.51%–11.5%, P = .03) greater total vBMD; findings were similar for length of reproductive life. A 10-year difference in HRT use was associated with a 6.0% (95% CI 2.6%–9.3%, P < .001) greater polar SSI and a 0.9% (95% CI 0.4%–1.5%, P = .001) greater cortical vBMD. These estimates changed little on adjustment. Estimates for aBMD were consistent with those for peripheral quantitative computed tomography. CONCLUSIONS: The positive effects on trabecular vBMD of later natural menopause and longer reproductive life persisted into early old age. HRT use was associated with greater radius cortical vBMD and polar SSI and aBMD.
format Online
Article
Text
id pubmed-5052353
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-50523532016-10-18 Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort Kuh, D. Muthuri, S. Cooper, R. Moore, A. Mackinnon, K. Cooper, C. Adams, J. E. Hardy, R. Ward, K. A. J Clin Endocrinol Metab Original Articles CONTEXT: Previous studies of menopausal age and length of reproductive life on bone are limited by retrospective reproductive histories, being cross-sectional, or lacking gold standard bone technologies or information on hormone replacement therapy (HRT) or surgical treatment. OBJECTIVE: The objective of the study was to investigate age at menopause, length of reproductive life, and HRT use in relation to volumetric and areal bone mineral density (vBMD, aBMD), bone size, and strength in women aged 60–64 years. DESIGN: This was a birth cohort study that followed up for 64 years with prospective measures of age at menarche and menopause and monthly HRT histories. SETTING: The study was conducted in England, Scotland, and Wales. PARTICIPANTS: Participants included 848 women with a known type of menopause and bone measures at 60–64 years. MAIN OUTCOME MEASURES: Peripheral quantitative computed tomography measurements of the distal radius total and trabecular vBMD were measured. Diaphyseal radius total and medullary cross-sectional area, cortical vBMD, and polar strength strain index (SSI); dual-energy x-ray absorptiometry measurements of aBMD at the lumbar spine and total hip were also measured. RESULTS: A 10-year increase in age at natural (but not surgical) menopause was associated with 8.2% (95% confidence interval [CI] 1.3%–15.1%, P = .02) greater trabecular vBMD and a 6.0% (95% CI 0.51%–11.5%, P = .03) greater total vBMD; findings were similar for length of reproductive life. A 10-year difference in HRT use was associated with a 6.0% (95% CI 2.6%–9.3%, P < .001) greater polar SSI and a 0.9% (95% CI 0.4%–1.5%, P = .001) greater cortical vBMD. These estimates changed little on adjustment. Estimates for aBMD were consistent with those for peripheral quantitative computed tomography. CONCLUSIONS: The positive effects on trabecular vBMD of later natural menopause and longer reproductive life persisted into early old age. HRT use was associated with greater radius cortical vBMD and polar SSI and aBMD. Endocrine Society 2016-10 2016-07-29 /pmc/articles/PMC5052353/ /pubmed/27472291 http://dx.doi.org/10.1210/jc.2016-1828 Text en https://creativecommons.org/licenses/by/4.0/ This article has been published under the terms of the Creative Commons Attribution License (CC-BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is reatined by the author(s).
spellingShingle Original Articles
Kuh, D.
Muthuri, S.
Cooper, R.
Moore, A.
Mackinnon, K.
Cooper, C.
Adams, J. E.
Hardy, R.
Ward, K. A.
Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title_full Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title_fullStr Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title_full_unstemmed Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title_short Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60–64 Years: A British Birth Cohort
title_sort menopause, reproductive life, hormone replacement therapy, and bone phenotype at age 60–64 years: a british birth cohort
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052353/
https://www.ncbi.nlm.nih.gov/pubmed/27472291
http://dx.doi.org/10.1210/jc.2016-1828
work_keys_str_mv AT kuhd menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT muthuris menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT cooperr menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT moorea menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT mackinnonk menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT cooperc menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT adamsje menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT hardyr menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort
AT wardka menopausereproductivelifehormonereplacementtherapyandbonephenotypeatage6064yearsabritishbirthcohort